Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trials

被引：0
|
作者：
Caiyun Zheng
Meimei Lin
Yan Chen
Haiting Xu
Lingqun Yan
Hengfen Dai
机构：
[1] Affiliated Fuqing City Hospital of Fujian Medical University,
[2] Fujian Medical University,undefined
[3] Affiliated Fuzhou First Hospital of Fujian Medical University,undefined
来源：
Cardiovascular Diabetology | / 20卷
关键词：
Sodium glucose cotransporter type 2 inhibitors; Cardiovascular disease; Mortality; Meta‐analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effects of sodium-glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta-analysis of randomized controlled trials
    Zheng, Caiyun
    Lin, Meimei
    Chen, Yan
    Xu, Haiting
    Yan, Lingqun
    Dai, Hengfen
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [2] Cardiovascular Outcomes With the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease An Updated Meta-Analysis of Randomized Controlled Trials
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Goldberg, Michael
    Jain, Diwakar
    Frishman, William H.
    Aronow, Wilbert S.
    CARDIOLOGY IN REVIEW, 2020, 28 (03) : 116 - 124
  • [3] Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Jae Hyun Bae
    Eun-Gee Park
    Sunhee Kim
    Sin Gon Kim
    Seokyung Hahn
    Nam Hoon Kim
    Scientific Reports, 9
  • [4] Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Bae, Jae Hyun
    Park, Eun-Gee
    Kim, Sunhee
    Kim, Sin Gon
    Hahn, Seokyung
    Kim, Nam Hoon
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials
    Gong, Chen
    Shen, Shi-Chun
    Zhang, Ke
    Zhou, Lei
    Shen, Jun-Jie
    Zhao, Jia-Ying
    Ding, Sheng-Gang
    Ma, Li-kun
    Gao, Hui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [6] Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors in patients with type II diabetes mellitus: A meta-analysis of placebo-controlled randomized trials
    Saad, Marwan
    Mahmoud, Ahmed N.
    Elgendy, Islam Y.
    Abuzaid, Ahmed
    Barakat, Amr F.
    Elgendy, Akram Y.
    Al-Ani, Mohammad
    Mentias, Amgad
    Nairooz, Ramez
    Bavry, Anthony A.
    Mukherjee, Debabrata
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 228 : 352 - 358
  • [7] Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials
    Yao Neng Teo
    Adriel Z. H. Ting
    Yao Hao Teo
    Elliot Yeung Chong
    Joshua Teik Ann Tan
    Nicholas L. Syn
    Alys Z. Q. Chia
    How Ting Ong
    Alex Jia Yang Cheong
    Tony Yi-Wei Li
    Kian Keong Poh
    Tiong Cheng Yeo
    Mark Yan-Yee Chan
    Raymond C. C. Wong
    Ping Chai
    Ching-Hui Sia
    American Journal of Cardiovascular Drugs, 2022, 22 : 299 - 323
  • [8] Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials
    Teo, Yao Neng
    Ting, Adriel Z. H.
    Teo, Yao Hao
    Chong, Elliot Yeung
    Tan, Joshua Teik Ann
    Syn, Nicholas L.
    Chia, Alys Z. Q.
    Ong, How Ting
    Cheong, Alex Jia Yang
    Li, Tony Yi-Wei
    Poh, Kian Keong
    Yeo, Tiong Cheng
    Chan, Mark Yan-Yee
    Wong, Raymond C. C.
    Chai, Ping
    Sia, Ching-Hui
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) : 299 - 323
  • [9] Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials
    Kani, R.
    Watanabe, A.
    Miyamoto, Y.
    Kuno, T.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [10] Safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta-analysis of randomized controlled trials
    Rigato, Mauro
    Fadini, Gian Paolo
    Avogaro, Angelo
    DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 2963 - 2969
12345